Enduring responses after 1-year, fixed-duration cevostamab therapy in patients with relapsed/refractory multiple myeloma: Early experience from a phase I study Meeting Abstract
| Authors: | Lesokhin, A. M.; Richter, J.; Trudel, S.; Cohen, A. D.; Spencer, A.; Forsberg, P. A.; Laubach, J. P.; Thomas, S. K.; Bahlis, N. J.; Costa, L. J.; Otero, P. R.; Mateos, M. V.; Berdeja, J. G.; Kaedbey, R.; Krishnan, A. Y.; Fonseca, R.; Choeurng, V.; Cooper, J.; Sumiyoshi, T.; Wong, C.; Harrison, S. J. |
| Abstract Title: | Enduring responses after 1-year, fixed-duration cevostamab therapy in patients with relapsed/refractory multiple myeloma: Early experience from a phase I study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 4415 |
| End Page: | 4417 |
| Language: | English |
| ACCESSION: | WOS:000893223204189 |
| DOI: | 10.1182/blood-2022-157547 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
